Titan Pharmaceuticals Reports $763,000 Q3 Loss Titan Pharmaceuticals faces a $763,000 loss in Q3, impacting its financial outlook. Explore the Q3 results and future prospects in this financial report.
Nymox Pharmaceutical Corp. Posts Q3 Loss of $716,000 Nymox Pharmaceutical Corp. reports a Q3 loss of $716,000, equivalent to 1 cent per share. Discover the financial performance and insights into the company's future.
Shanghai Pharmaceuticals Expands Stake to 60% Shanghai Pharmaceuticals Holding Co. increases its stake from 50% to 60%, strengthening its market position. Discover the implications for the pharmaceutical industry.
Walgreens Boots Alliance Suffers 64% Decline in 2024 Discover why Walgreens Boots Alliance experienced a 64% drop in 2024. Explore the factors behind this significant loss in the pharmaceutical industry.
Sanofi to Increase Prices on Vaccines Sanofi plans to hike prices on its vaccine portfolio, impacting healthcare costs. Discover more about the upcoming changes in pharmaceutical pricing.
Pfizer Increases Prices on Over 60 Drugs, Including Paxlovid Pfizer raises drug prices, impacting over 60 medications such as Paxlovid. Explore how this price hike could affect the pharmaceutical market and consumers.
Veeva Systems Dominates Pharmaceutical CRM Market Veeva Systems Inc. commands over 80% of the market share in pharmaceutical-focused CRM software, leading the industry with innovative solutions.
Salesforce Wins Major Pharma Clients from Veeva Systems Salesforce Inc. captures key clients from Veeva Systems, including a top global pharma leader, signaling shifts in the competitive pharmaceutical industry.